| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 02/01/2011 | CA2502633C 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 02/01/2011 | CA2477931C O-cyclopropyl-carboxanilides and their use as fungicides |
| 02/01/2011 | CA2461218C Muscarinic agonists |
| 02/01/2011 | CA2418656C Proline derivatives and use thereof as drugs |
| 01/27/2011 | WO2011011598A1 Process for preparing 4- { (s) -2- (4-(4-chlorophenoxy) phenoxymethyl) pyrrolidin-1-yl) } butyric acid and salts thereof |
| 01/27/2011 | WO2010125578A3 Process for preparing lasofoxifene tartrate |
| 01/27/2011 | US20110021787 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 01/27/2011 | US20110021786 Pharmaceutical Solutions, Process of Preparation and Therapeutic Uses |
| 01/27/2011 | US20110021779 Process for the preparation of 6-substituted-1-(2h)-isoquinolinones |
| 01/27/2011 | US20110021761 Segmented Polymers and Their Conjugates |
| 01/27/2011 | US20110021597 3-phenoxymethylpyrrolidine compounds |
| 01/27/2011 | US20110021584 Methods and Assays for Detecting and Treating Hypoglycemia |
| 01/27/2011 | US20110021571 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 01/27/2011 | US20110021528 Novel hydroxamates as therapeutic agents |
| 01/27/2011 | US20110020324 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 01/27/2011 | US20110020231 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 01/26/2011 | EP2277858A1 Amide compound |
| 01/26/2011 | EP2277850A1 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| 01/26/2011 | EP2276733A2 Novel donor-acceptor fluorene scaffolds: a process and uses thereof |
| 01/26/2011 | EP2276731A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10 |
| 01/26/2011 | EP2276730A2 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/26/2011 | EP1638936B1 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 01/26/2011 | EP1581490B1 Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides |
| 01/26/2011 | EP1554239B1 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
| 01/26/2011 | CN101955458A 2,2-di [4-(2-trifluoromethyl-4-maleimide phenyloxy) phenyl] propane and preparation method thereof |
| 01/26/2011 | CN101955457A General preparation method of optical-activity 3-aminopyrrolidine, 3-alkyl amino piperidine and derivatives thereof |
| 01/26/2011 | CN101954296A Chiral catalyst for asymmetric Michael addition reaction and preparation method thereof |
| 01/26/2011 | CN101077875B Boronic ester and acid compounds, synthesis and uses |
| 01/25/2011 | US7877129 Magnetic resonance imaging apparatus and RF reception coil apparatus |
| 01/25/2011 | US7875732 Quaternary ammonium salt, electrolyte, electrolyte, solution and electrochemical device |
| 01/25/2011 | US7875731 Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)Carbonyl]-1H-pyrrole-1-heptanoic acid |
| 01/25/2011 | US7875611 Ion channel modulating compounds and uses thereof |
| 01/25/2011 | CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/25/2011 | CA2388468C Mediators of hedgehog signalling pathways, compositions and uses related thereto |
| 01/25/2011 | CA2175429C Pharmaceutical compositions and methods |
| 01/20/2011 | WO2011009047A2 Il-1ra-polymer conjugates |
| 01/20/2011 | WO2011008666A2 3-phenoxymethylpyrrolidine compounds |
| 01/20/2011 | WO2011007877A1 Method for producing optically active epoxy compound, ligand used in the method, complex, method for producing the ligand, and method for producing the complex |
| 01/20/2011 | WO2010132693A3 Oligomer-containing pyrrolidine compounds |
| 01/20/2011 | US20110015408 Sulfonylpyrrolidine modulators of androgen receptor function and method |
| 01/20/2011 | US20110015407 Method for the preparation of atorvastatin and intermediates used therein |
| 01/20/2011 | US20110015371 Inhibitors of interleukin-1 beta converting enzyme |
| 01/20/2011 | US20110015360 Dithiocarbamic esters |
| 01/20/2011 | US20110015248 Substituted heterocycles |
| 01/20/2011 | US20110015174 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 01/20/2011 | US20110015152 Diarylmethyl and related compounds |
| 01/20/2011 | US20110010985 Fuel Additive to Control Deposit Formation |
| 01/20/2011 | DE102010031301A1 Use of 1,3-dimethylpyrrolidone and/or 1,4-dimethylpyrrolidone as solvents, diluents, extractants, cleaning agents, degreasers, absorbents and/or dispersing agents, or a solvent and/or extractant in method for decomposition of gas mixtures |
| 01/20/2011 | CA2767372A1 3-phenoxymethylpyrrolidine compounds |
| 01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
| 01/19/2011 | EP2274293A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby |
| 01/19/2011 | EP2274281A1 Hcv protease inhibitors |
| 01/19/2011 | EP2035375B1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 01/19/2011 | EP1879862B1 Magnesium salts of hmg-coa reductase inhibitors |
| 01/19/2011 | CN1944403B Process for recovering NMP in lithium cell membrance sheet drying process |
| 01/19/2011 | CN101952249A Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives |
| 01/19/2011 | CN101948463A Method for synthesizing substituted pyrrole by cycloaddition reaction of 1, 3-diyne and primary amine |
| 01/19/2011 | CN101948419A Method for preparing methyl bismaleimide |
| 01/19/2011 | CN101948418A Hydroxyproline structure-containing HIV-1 protease inhibitor as well as preparation method and application thereof |
| 01/19/2011 | CN101429151B IDO restrainer containing (E)-4-(beta-bromo vinyl)benzoyloxy structure and preparation method thereof |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/19/2011 | CN101133021B Crystallisation and purification of glycopyrronium bromide |
| 01/19/2011 | CN101072773B Pyrrole derivatives having CRTH2 receptor antagonist activity |
| 01/18/2011 | US7872123 Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process making reaction products from cyclic α,β-unsaturated ketone substrates and nitroso substrates |
| 01/18/2011 | US7872029 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 01/18/2011 | CA2573219C Hepatitis c inhibitor dipeptide analogs |
| 01/18/2011 | CA2500964C Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/18/2011 | CA2321881C Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 01/13/2011 | WO2011006080A2 Flavoring compositions for savory applications |
| 01/13/2011 | WO2011005969A2 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
| 01/13/2011 | WO2011004972A2 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist |
| 01/13/2011 | WO2011004200A1 Novel pyrrole derivatives |
| 01/13/2011 | US20110009640 Bifunctional phenyl iso (thio) cyanates, processes and intermediates for their preparation |
| 01/13/2011 | US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/13/2011 | US20110009623 Selective growth of stable polymorphs |
| 01/13/2011 | US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient |
| 01/13/2011 | US20110009621 Supported transition metal complex and use thereof in catalysis |
| 01/13/2011 | US20110009617 Ruthenium Catalysts and Uses Thereof |
| 01/13/2011 | US20110009465 3-phenoxymethylpyrrolidine compounds |
| 01/13/2011 | US20110009439 Indene derivatives as pharmaceutical agents |
| 01/13/2011 | US20110009261 Chemical compounds |
| 01/13/2011 | US20110008261 Method to produce hyperpolarised amino acids and aminosulphonic acids |
| 01/13/2011 | CA2767734A1 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist |
| 01/13/2011 | CA2767112A1 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
| 01/12/2011 | EP2272827A1 Sulphonylpyrroles as hdac inhibitors |
| 01/12/2011 | EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds |
| 01/12/2011 | EP2081890B1 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors |
| 01/12/2011 | EP1517907B1 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 01/12/2011 | CN101945853A Selective androgen receptor modulators (sarms) and uses thereof |
| 01/12/2011 | CN101945851A Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors |
| 01/12/2011 | CN101941935A Method for preparing 2,2-bi[4-(2-trifluoromethyl-4-maleimidephenoxy)phenyl] hexafluoropropane |
| 01/12/2011 | CN101941934A 4,4'-bi-(4-maleimide-2-trifluoromethanephenoxy)biphenyl and preparation method thereof |
| 01/12/2011 | CN101941933A 2-methyl-1,4-di(2-trifluoromethyl-4-maleimide phenoxyl) benzene and preparation method thereof |
| 01/12/2011 | CN101941932A Preparation method for 1, 3-di(4-bismaleimide-2-trifluoromethyl phenoxy) benzene |
| 01/12/2011 | CN101584694B Peptide deformylase inhibitor containing 2, 5-dihydropyrrole and synthesizing method |
| 01/12/2011 | CN101475522B Preparation of menthyl pyroglutamate |
| 01/12/2011 | CN101121687B N-substituted benzyl-alpha,alpha-disubstituted phenyl-2-pyrrolidinemethanol derivatives, preparation method and agricultural composition thereof |
| 01/11/2011 | US7868205 N-[2-amino-5-(2-thienyl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide; antiproliferative, antiprotozoal agent; lymphoma, lung cancer, colon cancer, prostrate cancer, stomach cancer, breast cancer, leukemia |
| 01/11/2011 | US7868188 Phosphatidylinositol (PI) 3-kinase (PI3K); N-[5-(5-Benzylamino-6-chloropyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]acetamide, for example; anticancer agents, cardiovascular disorders, autoimmune disorders, rheumatic diseases |